1405-9940

S1405-99402024000500001

10.24875/acm.m24000095

México

Reino Unido

México

Colombia

México

00 03 2024

94 1 74

2023 118 17 17

3272-87

2021 32 1 1

s8-s85

2023 29 10 10

1412-51

2022 145 18 18

2021 42 36 36

3599-726

2023

2015 6 6 6

329-34

2015 14 2 2

103-6

2022 79 91 91

2021 7 1 1

00318-2020

2021 7 1 1

00318-2020

2022 92 Supl Supl

1-69

2019 61 3 3

359-414

Scottish Intercollegiate Guidelines Network (SIGN). A guideline developer's handbook 2019

2024 10 92 92

2021 27 4 4

387-413

2000 320 7226 7226

39-42

1995 16 6 6

741-51

2021 32 S1 S1

8-85

2007 115 12 12

1563-70

2022 19 3 3

146-56

2018 72 19 19

2360-79

2015 31 6 6

792-9

2019 8 23 23

2016 22 7 7

569-77

2008 9 1 1

2009 13 32 32

2020 17 11 11

698-717

2021 21 2 2

1-125

Balion C DWAHSSPBRBJOMAUBASNMRRP 2013

2023 73 726 726

2021 13

2009 11 2 2

170-7

2018

Scottish Intercollegiate Guidelines Network (SIGN) 2016

2016 29 4 4

277-314

2021 76

116-22

2019 6 5 5

909-20

2011 11 1 1

2013 267 2 2

387-95

2022 108 3 3

194-202

2019 8 10 10

1757

2022 28 1 1

133-48

2022

2019 13

175394471987008

2010 21 1 1

13-21

2021 30 159 159

200187

2018 20 1 1

3-15

2020 25 6 6

993-1006

1993 71 12 12

1106-7

2014 19 3 3

359-67

2007 14 5 5

589-607

2011 64 1 1

51-8

2008 61 3 3

251-9

2021 37 4 4

531-46

Grupo de trabajo de la Guía de Práctica Clínica sobre Tratamiento de la Insuficiencia Cardiaca Crónica. 2016

2020 133 12 12

1391-402

2022 37 1 1

37-47

2022

2018 10 7 7

828

2018 10 1 1

2021 36 4 4

367-81

2022 28 1 1

193-206

2022 178

60-71

2021 8 1 1

2021 8 5 5

3458-71

2019 7 8 8

691-705

2021 29

2021 39 2 2

2020 110

103689

2017 94

317-25

2014 9

16-24

2010 17 1 1

2021

2012 155 1 1

33-8

2021 77 3 3

321-9

2020 7 2 2

2021 30 5 5

683-91

2022

2020 7 2 2

2022 36 5 5

915-24

2023 48 1 1

101412

2023 48 1 1

101412

2023 187

84-92

2022

2011 16 3-4 3-4

368-75

2017 10 1 1

2021 8 9 9

101

2021 2021 5 5

2018 20 9 9

1315-22

2022 292 2 2

333-49

2020 22 11 11

140

2022 5 9 9

2022 10 2 2

73-84

2019 21 S2 S2

19-23

2022 180

106243

2022 27 1 1

314

2022 9 2 2

942-6

2020 396 10254 10254

819-29

100

2023 24 2 2

123-31

101

2021 26 1 1

127-36

102

2020 7 3 3

892-902

103

2017 70 14 14

1777-84

104

2021 44 4 4

463-71

105

2021 26 1 1

157-63

106

2021 99 11 11

1159-74

107

2022 22

8-14

108

2020 12 10 10

501-11

109

2023 48 5 5

101586

110

2018 97 41 41

111

2018 53 3 3

119-20

112

2015

h4451

113

2015 36 28 28

1831-8

114

2017 2017

1-11

115

2021 2021 2 2

116

2021 22 4 4

1451

117

2014 9 5 5

118

2019 53 3 3

110-6

119

2017 4 1 1

120

2022

121

2022 146 4 4

339-57

122

2018 8 7 7

123

2021 37 4 4

644-54

124

2015 101 22 22

1800-6

125

2017 191

21-9

126

2019 27 3 3

160-6

127

2022 9 2 2

128

2016 4 10 10

772-9

129

2021 40 10 10

1098-106

130

2021 23 4 4

496-510

131

2021 14 6 6

132

2022 27 3 3

827-36

133

2022 28 3 3

443-52

134

2021 21 1 1

255

135

2022 3 5 5

482-92

136

2020

137

2022 70 5 5

1558-68

138

2017 136 5 5

440-50

139

2022 24 9 9

1218-25

140

2023 48 3 3

101034

141

2022 2022 11 11

142

2016 68 3 3

642-53

143

American Diabetes Association Professional Practice Committee. 7.

2019 42 January January

S71-80

144

2020 41 2 2

255-323

145

2023 187

93-9

146

2022 2022

1-16

147

2022 182

106345

148

2022

149

2020 7 6 6

3487-96

150

2022 361

40-6

151

2022 18 3 3

433-8

152

2022 27 1 1

314

153

2023 25 7 7

1094-104

154

2021 8 1 1

634-43

155

2020 73 8 8

643-51

156

2021

ccd.29703

157

2021 10 1 1

1-14

158

2018 13 5 5

159

2020 8 7 7

557-68

160

2020 20 4 4

1137-51

161

2021 10 2 2

186-208

162

2021 10 2 2

209-20

163

2022 27 4 4

1053-61

164

2017 52 1 1

14-25

165

2017 38 47 47

3523-31

166

2007 167 14 14

1493

167

2021 128 10 10

1468-86